Host-guest interaction between Ofloxacin-β-Cyclodextrin complexes in acidic and neutral pH: A fluorescence quenching study

Fluorescence turn-off sensing strategy based on Al-based MOF for selective detection of tricresyl phosphate

Tricresyl phosphate (TCP), a notable emerging pollutant with a high bioconcentration factor and biotoxicity, is a typical representative of aryl-organophosphorus flame retardants. The electrochemical and chromatographic technologies used in conventional TCP detection have a variety of drawbacks. Hence, it is crucial to suggest an easy, accurate, and selective method for detecting TCP. In this study, we presented a brand-new method based on NH₂-MIL-53(Al) nanoprobe for the direct luminescence assay of TCP. NH₂-MIL-53(Al) possessed an excellent crystal structure and superior optical qualities. Notably, the introduction of TCP caused a considerable dampening of the photoluminescence signal of the nanoprobe. The fluorescence response based on static quenching was verified by fluorescence lifetime decay curves. The thermodynamic analysis further concluded that TCP and nanoprobe spontaneously produced non-fluorescent complexes due to hydrophobic interaction. The quenching efficiency (F₀-F)/F₀ of the nanoprobe and the TCP concentration displayed good linearity in the scope of 0.3-3.0 μM (R² = 0.996), and the LOD was 0.058 μM under the ideal detection conditions. More significantly, the technique was effectively used to identify TCP in lake and tap water (RSD ≤5.79%), which provided a fresh perspective on how to recognize OPFRs in environmental water.

Enhanced antibacterial activity of levofloxacin/hydroxypropyl-β-cyclodextrin inclusion complex: In vitro and in vivo evaluation

Levofloxacin is the levo-enantiomer of ofloxacin (a fluoroquinolone class of antibacterial drug). Cyclodextrins (CDs) including hydroxypropyl-β-cyclodextrin (HPβCD) are generally used as a chiral selector for the enantioseparation of some drugs including levofloxacin or as a drug/food nanocarrier for the efficacy improvement of many pharmaceuticals. We hypothesized that the cyclodextrin inclusion is potentially able to further improve the antibacterial activity of levofloxacin. To test this hypothesis, the levofloxacin/HPβCD inclusion complex was prepared by the freeze-drying method and characterized by phase solubility diagram, differential scanning calorimetry (DSC), X-ray diffractometry (XRD), UV-Vis spectrophotometer, and ¹H NMR spectroscopy, confirming the successful HPβCD inclusion of levofloxacin. The in vitro antibacterial effects of HPβCD, levofloxacin, and the levofloxacin/HPβCD inclusion complex against four different bacterial strains in liquid media and on agar plates were determined/compared (an MIC₉₀ of 0.5-1.0 μg/mL for the inclusion complex compared with that of 1.0-2.0 μg/mL for free levofloxacin in liquid). Moreover, the in vivo antibacterial effects of levofloxacin and levofloxacin/HPβCD inclusion complex were tested by using a skin scald model in mice infected with Staphylococcus aureus, and decreased amounts of both bacteria and leukocytes were detected in scalded skin after the inclusion complex treatment. The data revealed that the levofloxacin/HPβCD inclusion complex had an enhanced antibacterial activity compared with free levofloxacin. It implies that cyclodextrins (e.g. HPβCD) may have a beneficial role when using as a chiral selector or as a drug nanocarrier for levofloxacin and that the levofloxacin/HPβCD inclusion complex has the potential of being developed into a pharmaceutical for antibacterial therapies.

Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-Delivery Systems—A Pharmaceutical Perspective

Cyclodextrins (CDs) are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of glucose subunits linked by α-1,4 glycosidic bonds. The shape of CD molecules is similar to a truncated cone with a hydrophobic inner cavity and a hydrophilic surface, which allows the formation of inclusion complexes with various molecules. This review article summarises over 200 reports published by the end of 2021 that discuss the complexation of CDs with antibiotics and antibacterial agents, including beta-lactams, tetracyclines, quinolones, macrolides, aminoglycosides, glycopeptides, polypeptides, nitroimidazoles, and oxazolidinones. The review focuses on drug-delivery applications such as improving solubility, modifying the drug-release profile, slowing down the degradation of the drug, improving biological membrane permeability, and enhancing antimicrobial activity. In addition to simple drug/CD combinations, ternary systems with additional auxiliary substances have been described, as well as more sophisticated drug-delivery systems including nanosponges, nanofibres, nanoparticles, microparticles, liposomes, hydrogels, and macromolecules. Depending on the desired properties of the drug product, an accelerated or prolonged dissolution profile can be achieved when combining CD with antibiotics or antimicrobial agents.

An On-off Supramolecular Fluorescence Switch for Detection of Pb2+ Ions and Vitamin C

β-cyclodextrin-hydroxyquinoline functionalized graphene oxide (GO-CD-HQ) was facilely fabricated to monitor and quantitatively analyze cations in aqueous media. The optical probe was notably selective enhanced toward Pb²⁺ ions over the other tested ions like Cu²⁺, Hg²⁺, Ca²⁺, Na⁺, K⁺, Zn²⁺, Fe²⁺, Fe³⁺, Ag⁺, Mg²⁺, and Cd²⁺ at 468 nm as an emission wavelength. The probe was shown the best performance in pH value, 5, and optimum time 1 min. Absorption spectra have clearly confirmed the static type fluorescence enhancement mechanism of GO-CD-HQ. Under the optimal conditions, the detection limit of it and linear concentration range for Pb²⁺ ions were obtained as 3.72 × 10^-5 M and (5-60) × 10^-5 M, respectively. Additionally, the developed assay exhibited logic gate behavior with Pb²⁺ ions and vitamin C as a masking agent for cited ions.

Fluorescence quenching of p-tert-buthylthiacalix[4]arene by 1-ethyl-3-methylimidazolium bromide

The interaction between the ionic liquid 1-ethyl-3-methylimidazolium bromide (EMIMBr) and the macrocyclic compound p-tert-buthylthiacalix[4]arene (TC4) in solution ethanol/water 3/1 V/V was investigated by spectrophotometry and spectrofluorimetry. The UV-Vis spectra of the system (EMIMBr + TC4) were completely additive. The addition of EMIMBr decreases the fluorescence of the TC4 significantly, excited at 325.0 nm. The Stern-Volmer quenching constants were determined at different temperatures (15.0, 25.0, and 35.0 °C), and the obtained values were the same, with an average value of K_Q^av = (3.8 ± 0.9) 10³ M^-1 for the quenching constant. No changes in the emission spectra of TC4 were obtained by the addition of inorganic salts, such as NaCl, KBr, NH₄Cl, and NH₄PF₆ or the organic compound N-methylimidazole (NMI). More evidence of EMIMBr-TC4 interaction was found with the determination of the fluorescence lifetime and the anisotropy of the mixture. Also, the slope of the quenching plot was the analytical sensitivity of calibration for EMIMBr using TC4 as an indirect sensor, and a LOD = (26 ± 2) μM was obtained.

Thermodynamic and detailed kinetic study of the formation of orthophthalaldehyde-agmatine complex by fluorescence intensities

The aim of this work is to determine the thermodynamic parameters and the kinetics of complex formation between orthophthalaldehyde (OPA) and agmatine (AGM) in an alkaline medium (pH 13). Firstly, the association constant (Ka) between orthophthalaldehyde and agmatine was determined at different temperatures (between 298 K and 338 K) with a step size of 10 K. Secondly, the thermodynamic parameters such as standard enthalpy (ΔH°), standard entropy (ΔS°),and Gibbs energy (∆G) were calculated, where a positive value of ΔH° (+45.50 kJ/mol) was found, which shows that the reaction is endothermic. In addition, the low value of ΔS°(+0.24 kJ/mol) indicates a slight increase in the disorder in the reaction medium. Furthermore, the negative values of ΔG between −35.62 kJ/mol and −26.02 kJ/mol show that the complex formation process is spontaneous. Finally, the parameters of the kinetics of the reaction between OPA and AGM were determined as follows: when the initial concentration of AGM (5 × 10−6 M) is equal to that of the OPA, the results show that the reaction follows an overall 1.5 order kinetics with an initial rate of 5.1 × 10−7Mmin−1 and a half-life of 8.12 min. The partial order found in relation to the AGM is 0.8. This work shows that the excess of OPA accelerates the formation reaction of the complex.

Stimulatory Effects of Methyl-β-cyclodextrin on Spiramycin Production and Physical-Chemical Characterization of Nonhost@Guest Complexes

Spiramycin is a macrolide antibiotic and antiparasitic that is used to treat toxoplasmosis and various other infections of soft tissues. In the current study, we evaluated the effects of α-cyclodextrin, β-cyclodextrin, or methyl-β-cyclodextrin supplementation to a synthetic culture medium on biomass and spiramycin production by Streptomyces ambofaciens ATCC 23877. We found a high stimulatory effect on spiramycin production when the culture medium was supplemented with 0.5% (w/v) methyl-β-cyclodextrin, whereas α-cyclodextrin or β-cyclodextrin weakly enhanced antibiotic yields. As the stimulation of antibiotic production could be because of spiramycin complexation with cyclodextrins with effects on antibiotic stability and/or efflux, we analyzed the possible formation of complexes by physical-chemical methods. The results of Job plot experiment highlighted the formation of a nonhost@guest complex methyl-β-cyclodextrin@spiramycin I in the stoichiometric ratio of 3:1 while they excluded the formation of complex between spiramycin I and α- or β-cyclodextrin. Fourier-transform infrared spectroscopy measurements were then carried out to characterize the methyl-β-cyclodextrin@spiramycin I complex and individuate the chemical groups involved in the binding mechanism. These findings may help to improve the spiramycin fermentation process, providing at the same time a new device for better delivery of the antibiotic at the site of infection by methyl-β-cyclodextrin complexation, as it has been well-documented for other bioactive molecules.